CXCL9 and neoplasm: Taken together, these results demonstrated that NPSur-C9AP could be used as a universal gene nanomedicine to enhance T-cell recruitment and activation in multiple tumors for enhanced immunotherapy via tumor-specific coexpression of CXCL9 and αPD-L1.